1109 Calliditas Reata kidney wins
BioCentury & Getty Images

Product Development

Reata, Calliditas make good on renewed interest in kidney disease with Phase III successes

Nov 10, 2020 | 3:23 AM GMT

Two renal diseases are on track for their first approvals after a pair of Phase III studies hit primary endpoints, suggesting renewed interest in the therapeutic area is

Read the full 579 word article

How to gain access

Continue reading with a
two-week free trial.